Gilead Sciences Inc. sees 2025 earnings rising faster than Wall Street expected after a big fourth-quarter beat highlighted ...

Investors led by Elon Musk offer $97.4 billion for OpenAI. Sam Altman replies: 'No thank you.' ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

He took part in 28 HIV drug trials under the care of immunologist ... how to use them properly and which were the best combinations.

Kevin McKenna, a Labour MP for Sittingbourne and Sheppey in Kent, opened up about his diagnosis during a debate in Westminster Hall yesterday, where he encouraged people to ‘just get tested’, adding: ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.

Rosuvastatin has possible interactions with alcohol, some other drugs, and certain supplements. Examples include antacids ...

Both drugs, administered orally once daily, are indicated for the treatment of HIV in adult patients with no prior antiretroviral in combination with other HIV medications. The approval of both ...

I fully expect to see an exponential increase in new HIV infections,” one expert said. Women and girls are more susceptible ...

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free voluntary licensing agreements with six generic manufacturers, paving the ...